Correlation Between Elevation Oncology and Kronos Bio

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Elevation Oncology and Kronos Bio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Elevation Oncology and Kronos Bio into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Elevation Oncology and Kronos Bio, you can compare the effects of market volatilities on Elevation Oncology and Kronos Bio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Elevation Oncology with a short position of Kronos Bio. Check out your portfolio center. Please also check ongoing floating volatility patterns of Elevation Oncology and Kronos Bio.

Diversification Opportunities for Elevation Oncology and Kronos Bio

0.32
  Correlation Coefficient

Weak diversification

The 3 months correlation between Elevation and Kronos is 0.32. Overlapping area represents the amount of risk that can be diversified away by holding Elevation Oncology and Kronos Bio in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Kronos Bio and Elevation Oncology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Elevation Oncology are associated (or correlated) with Kronos Bio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Kronos Bio has no effect on the direction of Elevation Oncology i.e., Elevation Oncology and Kronos Bio go up and down completely randomly.

Pair Corralation between Elevation Oncology and Kronos Bio

Given the investment horizon of 90 days Elevation Oncology is expected to under-perform the Kronos Bio. In addition to that, Elevation Oncology is 2.46 times more volatile than Kronos Bio. It trades about -0.09 of its total potential returns per unit of risk. Kronos Bio is currently generating about -0.1 per unit of volatility. If you would invest  102.00  in Kronos Bio on November 28, 2024 and sell it today you would lose (4.00) from holding Kronos Bio or give up 3.92% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Elevation Oncology  vs.  Kronos Bio

 Performance 
       Timeline  
Elevation Oncology 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Elevation Oncology has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly stable technical and fundamental indicators, Elevation Oncology is not utilizing all of its potentials. The current stock price fuss, may contribute to near-short-term losses for the sophisticated investors.
Kronos Bio 

Risk-Adjusted Performance

Weak

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Kronos Bio are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of very healthy basic indicators, Kronos Bio is not utilizing all of its potentials. The recent stock price disarray, may contribute to short-term losses for the investors.

Elevation Oncology and Kronos Bio Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Elevation Oncology and Kronos Bio

The main advantage of trading using opposite Elevation Oncology and Kronos Bio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Elevation Oncology position performs unexpectedly, Kronos Bio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Kronos Bio will offset losses from the drop in Kronos Bio's long position.
The idea behind Elevation Oncology and Kronos Bio pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.

Other Complementary Tools

Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets